CellCarta

CellCarta CellCarta, formely Caprion-HistoGenex CellCarta, formely Caprion-HistoGeneX.

CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late stage clinical trials. The company operates globally with 9 facilities located in Canada, USA, Belgium, Australia, and China.

06/03/2026

When you're looking for high parameter flow data for clinical trials, one option is spectral flow cytometry. With spectral flow, analysts can identify and quantify over 40 fluorochromes simultaneously for more detailed information about cell populations and biomarkers in a single sample.

At , make sure to find Xavier Dagenais-Lussier, Senior Scientist to learn how CellCarta scientists are accelerating assay design for clinical trials with flexible panel design.

The team will be at Booth #606 - book a meeting to make sure you catch them 👩‍🔬👨‍🔬 https://buff.ly/TqLZjT6

We caught a few CellCarta team members at the sign! We're thrilled to be in Chicago discussing how we can accelerate y...
06/01/2026

We caught a few CellCarta team members at the sign!

We're thrilled to be in Chicago discussing how we can accelerate your oncology programs from early stages to CDx development with our integrated capabilities across immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions.

Haven't caught the team? We're always available to discuss your programs- send us a message 📩 https://buff.ly/w8iZWQ8

05/29/2026

Press Release: CellCarta and Leica Biosystems are expanding their proven companion diagnostic (CDx) joint development model to biopharma sponsors worldwide.

Built on operational success in China, this partnership introduces a flexible, end-to-end CDx development framework that aligns assay development, clinical trial ex*****on, regulatory strategy, and commercial kit planning within a single coordinated model, while accommodating diverse regulatory pathways.

The result: a lower-risk, more streamlined path from early-stage assay to global CDx commercialization.

The partnership also leverages the integration of advanced digital pathology, combining Leica Biosystems' Aperio Scanners, IMS platform and expanding AI-enabled ecosystem with CellCarta's globally standardized digital pathology infrastructure for clinical trials.

Read the full announcement: https://buff.ly/iRwhnEL

05/28/2026

CellCarta is attending ! The team is showing off CellEngine, our fast and flexible flow cytometry analysis software built to make your data analysis faster and more straightforward. Visit us at Booth 606!

Plus, look out for our poster: Accelerating spectral flow cytometry assay development for clinical trials with a flexible panel design.

Whether you're looking to analyze your existing data or a partner for clinical flow cytometry assay development, make sure to reach out: https://buff.ly/TqLZjT6

05/27/2026

Big news: CellCarta and Sonic Healthcare USA are partnering to bridge companion diagnostic development and commercial deployment. We could not be more excited about what this means for our biopharma partners.

Bringing a companion diagnostic through regulatory approval is only half the journey. Getting that test into the hands of physicians and patients at scale has historically been one of the hardest problems in precision medicine.

This partnership is designed to solve that challenge.

Sonic Healthcare USA becomes the first committed commercial laboratory partner in CellCarta's Lab Network, supporting our single-site PMA CDx bridging strategy across oncology, autoimmune disease, and other precision medicine programs.

Learn more: https://buff.ly/T5ZM9i9

Join us at ASCO! We support oncology programs in generating reliable, regulatory-ready data with integrated capabilities...
05/25/2026

Join us at ASCO!

We support oncology programs in generating reliable, regulatory-ready data with integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions.

Let's talk! Book a meeting with our team: https://buff.ly/6Eh8B4K

We're excited to learn more about your programs!

05/22/2026

The CellCarta team is heading to Chicago for ASCO! If you'll be there, make sure to book a meeting with the team to learn how we can support your programs from early stages to CDx development.

With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions.

Book a meeting with the team here: https://buff.ly/Qj4Z4Xn

05/21/2026

The quality and rigor of your early-stage programs determines the success of your therapeutic development. Our California laboratory helps teams generate insights quickly and confidently.

Get the insights your early-stage program needs, fast. Learn how our California lab can help: https://buff.ly/6q1VEBY

05/20/2026

Changing gate positions manually can make your cytometry analysis take orders of magnitude longer. Now, easier and simpler analysis is within reach!

Automatic gating tools are available in CellEngine, our cytometry analysis platform. Using machine learning algorithms, it adjusts gate placement to fit sample data, speeding up your analysis.

Want to learn more? Check it our for yourself👉 https://buff.ly/LGim7Uf

05/19/2026

Our 3rd annual CellCarta Connect Challenge event is on tomorrow, May 20th, in Shanghai. This scientific symposium brings together leading scientists and clinicians at the intersection of oncology, biomarkers, and diagnostics.

If you or your team are in China, register to hear from leading experts on topics including:

🌟 Biomarker driven drug development in colorectal cancer and lung cancer
🌟 Computational pathology in ADC treatment
🌟 Co-evolution of drugs and diagnostics in CDC
🌟 CDx development in China , from local development to global impact

Don't miss out- register today! https://buff.ly/Osl8Tl3

Address

201 President Kennedy Avenue , Suite 3900
Montreal, QC
H2X3Y7

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm

Telephone

+15143603600

Website

Alerts

Be the first to know and let us send you an email when CellCarta posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CellCarta:

Shortcuts

Share

Category